New Blood Test to Detect Kidney Transplant Rejection
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a kidney transplant recipient or about to receive a new kidney (from a living or deceased donor).
- You are an adult, 18 years or older.
- You are willing and able to sign a consent form (paper or electronic) agreeing to take part in this study.
- You must be treated at a specific hospital (St. Orsola Hospital in Bologna).
- (A separate group includes healthy blood donors, but that group does not require your consent.)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood test that may help monitor kidney transplant health by detecting signs of rejection earlier. It aims to see if using this blood test can lead to better long-term outcomes for transplant recipients.
This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This study tests a new medicine called TNX-1500 that may help prevent the body from rejecting a new kidney. It is for people who are already waiting for a kidney transplant and aims to make the transplant more successful.
This study looks at a new blood test to help monitor the health of your transplanted kidney and check for early signs of rejection. The test will be done as part of your usual care after a kidney transplant.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
Hear when a new Kidney Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.